Renal fibrosis: Insights into pathogenesis and treatment

International Journal of Biochemistry and Cell Biology

Volumn 29, Issue 1, 1997, Pages 55-62

  El Nahas, A M ^a   Muchaneta Kubara, E C ^a   Essawy, M ^a   Soylemezoglu, O ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Chemokines; Chronic renal failure; Cytokines; Glomerulosclerosis; Growth factors; Tubulointerstitial fibrosis

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; DECORIN; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTERIOSCLEROSIS; CELL INTERACTION; CELL PROLIFERATION; CHRONIC KIDNEY FAILURE; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; INFLAMMATORY CELL; KIDNEY FIBROSIS; NONHUMAN; REVIEW; SCAR FORMATION;

ANIMALS; FIBROSIS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; NEPHRITIS, INTERSTITIAL;

EID: 0031028553     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(96)00119-7     Document Type: Review

References (67)

1. Abboud H. E. (1993) Growth factors in glomerulonephritis. Kidney Int. 43, 252-267.
2. Abbate M. and Remuzzi G. (1995) Innovative strategies for pharmacological interventions in immune damage to the kidney. Nephrol. Dial. Transpl. 10, 1131-1136.
3. Adam A., Goumenos D., Brown C. B., Shortland J. and El Nahas A. M. (1995) Phenotypic modulation of renal cells in the course of mesangiocapillary glomerulonephritis. J. Am. Soc. Nephrol. 6, 1008.
4. Alexopoulos E., Seron D., Hartley B., Nolasco F. and Cameron J. S. (1989) Immune mechanisms in idiopathic membranous nephropathy: the role of the interstitial infiltrate. Am. J. Kidney Dis. 13, 404-412 .
5. Alpers C. E., Hudkins K. L., Gown A. M. and Johnson R. J. (1992) Enhanced expression of 'muscle specific' actin in glomerulonephritis. Kidnev Int. 41, 1134-1142.
6. Arthur M. (1995) Pathogenesis, experimental manipulation and treatment of liver fibrosis. Exp. Nephrol. 3, 90-95.
7. Border W. A., Okuda S., Languino L. R. and Ruoslahti E. (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factors I. Nature 346, 371-374.
8. Border W. A., Noble N. A., Yamamoto T., Harper J. R., Yamaguchi Y., Pierschbacher M. D. and Ruoslahti E. (1992) Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360, 361-364.
9. Border W. A, and Noble N. A. (1993) Cytokines in kidney disease: the role of transforming growth factor-β. Am. J. Kidney. Dis. 22, 105-113.
10. Brady H. R. (1994) Leukocyte adhesion molecules and kidney diseases. Kidney Int. 45, 1285-1300.
11. Cameron J. S. (1992) Tubular and interstitial factors in the progression of glomerulonephritis. Pediat. Nephrol. 6, 292-303.
12. Davies M. and Lovett D. H. (1995) Metalloproteinases, In Molecular Nephrology. Kidney Function in Health and Disease. (Eds Schlondorfif, D. and Bonventre, J. V.), pp. 61-69. Marcel Dekker Inc, New York, Basel and Hong Kong.
13. Desmouliere A., Redard M., Darby I. and Gabbiani G. (1995) Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am. J. Pathol. 146, 56-66.
14. Eddy A. A. (1995) Interstitial macrophages as mediators of renal fibrosis. Exp. Nephrol. 3, 76-79.
15. Eddy A. A., Giachelli C. M., McCulloch L. and Liu E. (1995) Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int. 47, 1546-1557.
16. El Nahas A. M. (1988) Glomerulosclerosis: a form of atherosclerosis. In Nephrology (Ed. Davison A. M.), pp. 1206-1218 Balliere Tindall (publisher) London.
17. El Nahas A. M. and Wight J. P. (1991) The management of chronic renal failure: ten unanswered questions. Quart. J. Med. 81, 799-809.
18. El Nahas A. M., Muchaneta-Kubara E. C., Zhang G., Adam A., Goumenos D. (1996) Phenotypic changes in the pathogenesis of renal scarring. Kidney Int. (in press).
19. Feest T. G., Mistry C. D., Grimes D. S. and Mallick N. P. (1990) Incidence of advanced chronic renal failure and the need for end-stage renal replacement treatment. Brit. Med. J. 301, 897-900.
20. Feng L., Xia Y., Yoshimura T. and Wilson C. B. (1996) Modulation of neutrophil influx in glomerulonephritis in the rat with anti-macrophage inflammatory protein-2 (MIP-2) antibody. J. Clin. Invest. 95, 1009-1017.
21. Floege J., Bums N. R. V., Alpers C. E., Yoshimura A., Pritzl P., Gordon K., Siefert R. A., Bowen-Pope D. F., Couser W. G. and Johnson R. J. (1992) Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int. 41, 297-309.
22. Floege J., Eng E., Young B. A., Alpers C. E., Barrett T. B., Bowen-Pope D. F. and Johnson R. J. (1993) Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial proliferation and matrix accumulation in rats. J. Clin. Invest. 92, 2952-2962.
23. Fukatsu A., Matsuo S., Tamai H., Sakamoto N., Matsuda T. and Hirano T. (1991) Distribution of interleukin-6 in normal and diseased human kidney. Lab. Invest. 65, 61-66.
24. Giachelli C. M., Pichler R., Lombardi D., Denhardt D. T., Alpers C., Schwartz S. and Johnson R. J. (1994) Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis. Kidney Int. 45, 515-524.
25. Gonzalez-Avila G., Vadillo-Ortiga F. and Perez-Tamayo R. (1988) Experimental diffuse interstitial fibrosis: a biochemical approach. Lab. Invest. 59, 245-252.
26. Gournenos D., Shortland J., Brown C. B. and El Nahas A. M. (1994) Myofibroblasts: predictors of progression of IgA nephropathy. Nephrol. Dial. Transpt. 9, 1418-1425.
27. Imai E., Aral M., Wada A. and Suguira T. et al., (1994) Phenotypic changes of the mesangial cells induced by overexpression of the TGF-β gene in in vivo glomeruli. J. Am. Soc. Nephrol. 5, 782.
28. Isaka Y., Fujiwara Y., Ueda N., Kaneda Y., Kamada T. and Imai E. (1993) Glomerulosclerosis induced by in vivo transfection of TGF-β or PDGF gene into the rat kidney. J. Clin. Invest. 92, 2597-2601.
29. Johnson R. J., Iida H. and Alpers C. E. et al., (1991) Expression of smooth muscle phenotype by rat mesangial cells in immune complex nephritis. J. Clin. Invest. 87, 847-858.
30. Johnson R. J. (1991) Platelets in inflammatory glomerular injury. Semin. Nephrol. 11, 276-284.
31. Johnson R. J., Raines E. W., Floege J., Yoshimura A., Pritzl P., Alpers C. E. and Ross R. (1992) Inhibition of mesangial cell proliferation and matrix deposition in glomerulonephritis in the rat by an antibody to platelet-derived growth factor. J. Exp. Med. 175, 1413-1416.
32. Johnson R. (1994) The glomerular response to injury: progression and resolution. Kidney Int. 45, 1769-1782.
33. Jones C. L., Fecondo J., Kelynack K., Forbes J., Walker R. and Becker G. (1995) Tissue inhibitor of the metalloproteinases and renal extracellular matrix accumulation. Exp. Nephrol. 3, 80-86.
34. Karkar A. M., Tam F. W. K., Proudfoot A. E. I., Meager A. and Rees A. J. (1993) Modulation of antibody-mediated glomerular injury in vivo by interleukin-6. Kidney Int. 44, 967-973.
35. Kashgarian M. and Sterzel R. B. (1992) The pathobiology of the mesangium. Kidney Int. 41, 524-529.
36. Kitamura M., Mitarai T., Maruyama N., Nagasawa R., Yoshida H. and Sakai O. (1991) Mesangial cell behavior in a three-dimensional extracellular matrix. Kidnev Int. 40, 653-661.
37. Kitamura M., Burton S., English J., Kawachi H. and Fine L. G. (1995) Transfer of a mutated gene encoding active transforming growth factor-β suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int. 48, 1747-1757.
38. Klahr S. (1993) Interstitial macrophages. Semin. Nephrol. 13. 4488-4502.
39. Klahr S., Heifets M. and Purkerson M. L. (1986) The influence of anticoagulation on the progression of experimental renal disease. Contemp. Issues in Nephrol. 14, 45-64.
40. Kline Bolton W. (1992) The nature of clinical trials in nephrology. Kidney Int. 42, 1061-1069.
41. Knecht A., Fine L. G. and Kleinman K. S. et al., (1991) Fibroblasts of rabbit kidney in culture. II. Paracrine stimulation of papillary fibroblasts by PDGF. Am. J. Physiol. 261, F292-F299.
42. Kovacs E. J. (1991) Fibrogenic cytokines: the role of immune mediators in the development of fibrosis. Immunol. Today 12, 17-23.
43. Kuncio G. S., Neilson E. G. and Haverty T. (1991) Mechanisms of tubulointerstitial fibrosis. Kidney Int. 39, 550-556.
44. Lakkis F. G., Baddoura F. K., Cruet E. N., Parekh K. R., Fukunaga M. and Munger K. A. (1996) Anti-inflammatory cytokines mRNA expression in antibody-induced glomerulonephritis. Kidney Int. 49, 117-126.
45. Lewis M. P., Fine L. G. and Norman J. T. (1996) Pexicrine effects of basement membrane components on paracrine signaling by renal tubular cells. Kidney Int. 49, 48-58.
46. Lonneman G., Shapiro L., Engler-Blum G., Muller G. A., Koch K. M. and Dinarello C. A. (1995) Cytokines in human interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int. 47, 837-844.
47. McAnulty R. J. and Laurent G. J. (1995) Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp. Nephrol. 3, 96-107.
48. Nikolic-Paterson D. J., Lan H. Y., Hill P. A. and Atkins R. C. (1994) Macrophages in renal injury. Kidney Int. 45, suppl 45, S79-S82.
49. Okuda S., Nakamura T., Yamamoto T., Ruoslahti E. and Border W. A. (1991) Dietary protein restriction rapidly reduces transforming growth factor-β1 expression in experimental glomerulonephritis. Proc. Natl Acad. Sci. U.S.A. 88, 9765-9769.
50. Ong A. C. M. and Fine L. G. (1994) Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. Am. J. Kidney Dis. 23, 205-209.
51. Paczek L., Teschner M., Schaefer R. M., Kovar J., Romen W. and Heidland A. (1992). Intraglomerular proteinase activity in adriamycin-induced nephropathy. Nephron 60, 81-86.
52. Risdon R. A., Sloper J. C. and De Waedener H. E. (1968) Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet 1, 363-366.
53. Roy-Chaudhury P., Wu B., King G., Campbell M., Macleod A. M., Haites N. E., Simpson J. G. and Power D. A. (1996) Adhesion molecule interactions in human glomerulonephritis: importance of the tubulointerstitium. Kidney Int. 49, 127-134.
54. Saito T. and Atkins R. C. (1990) Contribution of mononuclear leukocytes to the progression of experimental focal glomerular sclerosis. Kidney Int. 37, 1076-1083.
55. Sappino A. P., Schurch W. and Gabbiani G. (1990) Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulation. Lab. Invest. 63, 144-161.
56. Savage C. (1994) The biology of the glomerulus: endothelial cells. Kidney Int 45, 314-319.
57. Schaefer L., Han X., Gretz N., Hafner C., Meier K., Matzkies F. and Schaefer R. M. ( 1996) Tubular gelatinase A (MMP-2) and its tissue inhibitors in polycystic kidney disease in the Han: SPRD rat. Kidney Int. 49, 75-81.
58. Sharma A. K., Mauer S. M., Kim Y. and Michael A. F. (1993) Interstitial fibrosis in obstructive nephropathy. Kidney Int. 44, 774-788.
59. Silver B. L., Jaffer J. E. and Abboud H. E. (1989) Platelet-derived growth factor synthesis in mesangial cells: induction by multiple peptide mitogens. Proc. Natl Acad. Sci. U.S.A. 86, 1056-1060.
60. Stahl R. A. K. (1995) Chemoattractive cytokines (chemokines) and immune renal injury. Nephrol. Dial. Transpl, 10, 307-308.
61. Strutz F. (1995) The fibroblast-a (trans-) differentiated cell? Nephrol. Dial. Transpl. 10, 1504-1506.
62. Tam F. W. K., Karkar A. M., Smith J., Yoshimura T., Steinkasserer A., Kurrie R., Langner K. and Rees A. J. (1996) Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis. Kidney Int. 49, 715-721.
63. Tomosugi N. I., Cashman S. J., Hay H., Pusey C. D., Evans D. J., Shaw A. and Rees A. J. (1989) Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J. Immunol. 142, 3083-3090.
64. USRDS 1995 annual data report. II. Prevalence of ESRD therapy (1995) Am. J. Kidney Dis. 26,(suppl 2), S30-S38.
65. Wenzel U. O. and Abboud H. E. (1995) Chemokines and renal disease. Am. J. Kidney. Dis. 26, 982-994.
66. Yamamoto T., Noble N. A., Cohen A. H., Nast C. C., Hishida A., Gold L. I. and Border W. A. (1996) Expression of transforming growth factors isoforms in human glomerular diseases. Kidney Int. 49, 461-469.
67. Zhang G., Moorhead P. J. and El Nahas A. M. (1995) Myofibroblasts and the progression of experimental glomerulonephritis. Exp. Nephrol. 3, 308-318.